$6.9million for NSW Paediatric Rheum services!
So pleasantly surprised advocacy actually worked
So very needed after such a long slog
AMAZING😊 @JAFAforkids@AusRheum
https://t.co/VbwgX53Ers
If you’re just giving allopurinol at 300mg daily, you’re condemning up to 4/5 of patients to miss serum uric acid targets.
Allopurinol dosing is a massive cause of allopurinol failure.
Slow escalating to target is safe & effective, even in renal impairment
Lisa Stamp #ARANZRA24
and clinical remission doesn’t mean imaging remission necessarily, and that might be a problem. A real need to ensure non-steroid therapies truly modify disease #ARANZRA24
GUSTO trial (GCA treated with TCZ, and no steroids at all apart from an initial pulse):
1/18 had blindness
5/18 had aortic dilatation (update from Vasculitis 2024 Barcelona)
@MdWarrington asks: is TCZ really a disease modifying therapy in GCA?
#ARANZRA24
Diagnosing acute gout is critical on the front line - Nicola Dalbeth highlights this validated tool designed for ED and primary care
https://t.co/Quaw8wkn5r
#ARANZRA24
‘The P in prednisone stands for poison’
Problem is that P is also our most useful medication...
Can any of you name a medication you'd struggle without, if we no longer had it, in a rheum clinic?
https://t.co/hTxs8GHkIP
@AdamJBrownMD Of course. I don’t disagree and use it. I think what we would like are alternatives & at least there are some options starting to emerge
Longer acting & more effective steroid injections?
Would be useful in our clinics
#ACR23 presentation by @ProfDavidHunter
reported by @RheumaRepublic
https://t.co/rkUp4M0azM
L19 #ACR23@RheumNow
Hunter: TLC599 injxn for knee OA
Liposomal formulation of dexamathasone sodium phosphate
Improved WOMAC Pain, Fxn, and Aver Daily Pain
Separation of ADP at wk 12 through wk 24
2nd injxn at wk 24 - further benefit
@AusRheum